Evolving Role of Viltolarsen for Treatment of Duchenne Muscular Dystrophy
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2024/02/20
-
Journal
-
Indian UGC (journal)
-
Refrences33
-
LeighAnn Y. Vincik
-
Alexandra D. Dautel
-
Abigail A. Staples
-
Lillian V. Lauck
-
Catherine J. Armstrong
-
Jeffery T. Howard
-
David McGregor
-
Shahab Ahmadzadeh
-
Sahar Shekoohi ORCID (unauthenticated)
-
Alan D. Kaye
Cite
Vincik, LeighAnn Y., et al. “Evolving Role of Viltolarsen for Treatment of Duchenne Muscular Dystrophy”. Advances in Therapy, vol. 41, no. 4, 2024, pp. 1338-50, https://doi.org/10.1007/s12325-024-02801-4.
Vincik, L. Y., Dautel, A. D., Staples, A. A., Lauck, L. V., Armstrong, C. J., Howard, J. T., McGregor, D., Ahmadzadeh, S., Shekoohi, S., & Kaye, A. D. (2024). Evolving Role of Viltolarsen for Treatment of Duchenne Muscular Dystrophy. Advances in Therapy, 41(4), 1338-1350. https://doi.org/10.1007/s12325-024-02801-4
Vincik LY, Dautel AD, Staples AA, Lauck LV, Armstrong CJ, Howard JT, et al. Evolving Role of Viltolarsen for Treatment of Duchenne Muscular Dystrophy. Advances in Therapy. 2024;41(4):1338-50.
Journal Categories
Medicine
Medicine (General)
Medicine
Public aspects of medicine
Toxicology
Poisons
Medicine
Therapeutics
Pharmacology
You May Also Like
- Incidence, patient satisfaction, and perceptions of post-surgical pain: results from a US national survey
- Good and poor adherence: optimal cut-point for adherence measures using administrative claims data
- The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence oSf erectile dysfunction and related health concerns in the general population
- Screening Depressed Patients in Family Practice
- The Medical Risks of Obesity
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Delandistrogene Moxeparvovec: First Approval | Drugs |
| 18 | 2023 |
| 10.3233/JND-221656 | 2023 | |||
Prognostic factors, disease course, and treatment efficacy in Duchenne muscular dystrophy: A systematic review and meta‐analysis | Muscle & Nerve |
| 3 | 2022 |
Prognostic indicators of disease progression in Duchenne muscular dystrophy: A literature review and evidence synthesis | PLOS ONE |
| 8 | 2022 |
| 10.3233/JND-220811 | 2022 |
Refrences Analysis
The category
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry 7
is the most frequently represented among the references in this article. It primarily includes studies from Frontiers in Pharmacology The chart below illustrates the number of referenced publications per year.